Table 1.
Initial FDA authorisation date | Vaccine type | Number of doses for full immunisation | Age for which use was approved | |
---|---|---|---|---|
Pfizer-BioNTech* | Dec 11, 2020 | mRNA | Two | 12 years and older |
Moderna | Dec 18, 2020 | mRNA | Two | 18 years and older |
Janssen (Johnson & Johnson) | Feb 27, 2021 | Viral vector (adenovirus type 26) | One | 18 years and older |
FDA=US Food and Drug Administration.
The Pfizer-BioNTech vaccine received full FDA approval on Aug 23, 2021.